Literature DB >> 19685191

Adrenal morphology and function in acromegalic patients in relation to disease activity.

Alessandro Ciresi1, Marco C Amato, Calogero Vetro, Renato Lo Coco, Aldo Galluzzo, Carla Giordano.   

Abstract

Visceromegaly is a common consequence of acromegaly. However, few studies investigated the chronic effects of growth hormone on adrenal glands. Our aim was to evaluate adrenal morphology and function in a cohort of acromegalic patients in relation to disease activity. Twenty-six acromegalics (10 males and 16 females) and 21 healthy subjects were investigated. Gland morphology was evaluated by computerized axial tomography, measuring central, lateral, and medial adrenal segments. Uncontrolled acromegalics showed increased volume of all adrenal segments, higher urinary free cortisol (UFC), and lower morning adrenocorticotropic hormone in comparison with healthy subjects. However, normal cortisol levels after low-dose dexamethasone suppression test indicated a preserved regulation of the hypothalamic-pituitary-adrenal axis. In addition, uncontrolled patients showed greater medial segment of right gland, higher UFC, and aldosterone levels with respect to controlled patients. All acromegalics did not show any difference in adrenal size when grouped according to UFC/24 h levels. In addition, no difference was found in any of the parameters between normotensive and hypertensive patients. In conclusion, our findings confirm that acromegaly affects adrenal size as well as other organs. In addition, we report a stimulatory effect of growth hormone on adrenal function, although the regulation of the hypothalamic-pituitary-adrenal axis is preserved.

Entities:  

Mesh:

Year:  2009        PMID: 19685191     DOI: 10.1007/s12020-009-9230-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  20 in total

1.  Studies on the pathogenesis of hypertension in Cushing's disease and acromegaly.

Authors:  C M Ritchie; B Sheridan; R Fraser; D R Hadden; A L Kennedy; J Riddell; A B Atkinson
Journal:  Q J Med       Date:  1990-08

2.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

3.  A rare association between acromegaly and pheochromocytoma.

Authors:  J Baughan; C de Gara; D Morrish
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

4.  Basal and saline-stimulated levels of plasma atrial natriuretic factor in acromegaly.

Authors:  J A McKnight; D R McCance; D R Hadden; L Kennedy; G Roberts; B Sheridan; A B Atkinson
Journal:  Clin Endocrinol (Oxf)       Date:  1989-10       Impact factor: 3.478

5.  Acromegaly and pheochromocytoma: report of a rare coexistence.

Authors:  Gina G Sleilati; Kalman T Kovacs; Mahalakshmi Honasoge
Journal:  Endocr Pract       Date:  2002 Jan-Feb       Impact factor: 3.443

6.  Atrial natriuretic factor in patients with acromegaly.

Authors:  G Deray; P Chanson; G Maistre; A Warnet; J Eurin; C Barthelemy; F Masson; F Martinez; J Lubetzki; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  Abnormal plasma catecholamine responses in acromegalics.

Authors:  G R Van Loon
Journal:  J Clin Endocrinol Metab       Date:  1979-05       Impact factor: 5.958

8.  Adrenal morpho-functional alterations in patients with acromegaly.

Authors:  C Scaroni; R Selice; S Benedini; E De Menis; M Arosio; C Ronchi; M Gasperi; L Manetti; G Arnaldi; B Polenta; M Boscaro; N Albiger; E Martino; F Mantero
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

9.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

10.  Acromegaly and pituitary adenoma with phaeochromocytoma: a variant of multiple endocrine neoplasia.

Authors:  R J Anderson; E G Lufkin; G W Sizemore; J A Carney; S G Sheps; Y E Silliman
Journal:  Clin Endocrinol (Oxf)       Date:  1981-06       Impact factor: 3.478

View more
  2 in total

1.  Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?

Authors:  C T Bahadir; G C Ecemis; H Atmaca
Journal:  J Endocrinol Invest       Date:  2018-03-14       Impact factor: 4.256

2.  Case Report: A case report of acromegaly associated with primary aldosteronism.

Authors:  Joanna Matrozova; Silvia Vandeva; Sabina Zacharieva
Journal:  F1000Res       Date:  2014-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.